Dyne Therapeutics (DYN) Free Cash Flow (2019 - 2026)

Dyne Therapeutics' Free Cash Flow history runs 8 years deep, the most recent figure standing at -$145.0 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 36.89% year-over-year to -$145.0 million; the TTM figure through Mar 2026 stood at -$461.1 million (down 43.22% YoY), while the FY2025 annual figure was -$422.0 million, down 43.17% from the prior year.
• Free Cash Flow was -$145.0 million for Q1 2026 at Dyne Therapeutics, down from -$111.8 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$29.3 million in Q4 2022 to a low of -$145.0 million in Q1 2026.
• Historically, Free Cash Flow has averaged -$70.8 million across 5 years, with a median of -$55.4 million in 2023.
• Biggest YoY gain for Free Cash Flow was 30.82% in 2022; the steepest drop was 175.88% in 2022.
• A 5-year view of Free Cash Flow shows it stood at -$29.3 million in 2022, then fell by 21.97% to -$35.7 million in 2023, then tumbled by 142.7% to -$86.7 million in 2024, then fell by 29.04% to -$111.8 million in 2025, then fell by 29.66% to -$145.0 million in 2026.
• The last three Free Cash Flow figures came in at -$145.0 million (Q1 2026), -$111.8 million (Q4 2025), and -$109.2 million (Q3 2025), per Business Quant data.